The Readout Loud 257: Lilly's Alzheimer's success, a milestone FDA approval, & Moderna's shrinking business
May 4, 2023
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10
Introduction
00:00 • 3min
The Power of CAR T for Cancer
02:49 • 2min
Damon Moderna Reports Earnings for First Quarter
04:36 • 2min
The Decline of Lily Weight Loss Drugs
07:01 • 4min
The 60 Year Quest to Develop an RSV Vaccine
10:54 • 6min
The Amyloid Hypothesis and Alzheimer's
16:25 • 5min
The Implications of Dananamab for Patients
21:48 • 3min
Lekanumab and De-Nanomab: A Comparison
25:07 • 4min
The FDA's Decision to Reverse Course on Lequembe
29:34 • 2min
Adam Skvronsky's Personal Journey Through Alzheimer's
31:58 • 3min